Takeshi Okatani¹, Hideki Asaoku¹, Tsuyoshi Muta², Yuta Katayama¹, Tatsuya Terasaki¹, Takuya Nunomura¹, Fumiaki Jinnouchi¹, Ryota Imanaka¹, Kohei Kyo¹, Mitsuhiro Itagaki¹, Shinya Katsutani¹, Megumu Fujiwara³, Koji Iwato⁴ (1.Hematol., Hiroshima Red Cross Hosp. & Atomic-Bomb Survivors Hosp., Japan, 2.Transfusion, Hiroshima Red Cross Hosp. & Atomic-Bomb Survivors Hosp., Japan, 3.Pathol., Hiroshima Red Cross Hosp. & Atomic-Bomb Survivors Hosp., Japan, 4.Labo., Hiroshima Red Cross Hosp. & Atomic-Bomb Survivors Hosp., Japan)

Hiromichi Takahashi^1,2, Katsuhiro Miura¹, Kazuya Kurihara¹, Takashi Koike¹, Takashi Hamada¹, Masaru Nakagawa¹, Kazuhide Iizuka^1,2, Yoshihito Uchino¹, Noriyoshi Iriyama¹, Kazuyoshi Iizuka¹, Yoshihiro Hatta¹, Tomohiro Nakayama², Masami Takei¹ (1.Division of Hematology and Rheumatology, Nihon University School of Medicine, 2.Division of Laboratory Medicine, Nihon University School of Medicine)

Takashi Abe, Shoko Kitajima, Koji Nikkuni (Department of Hematology, Niigata City General Hospital, Niigata, Japan)

Yuki Iizuka, Masayuki Shiseki, Maya Kobayashi, Miki Umeda, Shoko Oshima, Satoko Osanai, Yutaka Kato, Michiko Ryuzaki, Satoru Itoi, Aya Watanabe, Norina Tanaka, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Junji Tanaka (Hematology, Tokyo Wemen's Medical Univercity, Tokyo, Japan)

Hiroki Yano, Tomoyuki Nakamura, Yu Asao (Hematology, Kainan Hospital, Yatomi, Japan)

Yuma Tada¹, Shigeo Fuji¹, Hiroaki Masaie¹, Hitoshi Yoshida¹, Satoru Kosugi², Hiroyuki Sugahara³, Shuji Ueda⁴, Hirohiko Shibayama⁵, Jun Ishikawa¹, Yuzuru Kanakura⁵ (1.Department of Hematology, Osaka International Cancer Institute, Osaka, Japan, 2.Department of Internal Medicine (hematology), Toyonaka Municipal Hospital, Osaka, Japan, 3.Department of Hematology, Sumitomo Hospital, Osaka, Japan, 4.Internal Medicine, Hyogo Prefectural Nishinomiya Hospital, Hyogo, Japan, 5.Department of Hematology and Oncology, Osaka University Hospital, Osaka, Japan)